Pennsylvania Gov. Calls for Legalization to Solve Budget Woes

8/26/2020

by

Pennsylvania Gov. Tom Wolf (D) on Tuesday called for the Legislature to legalize cannabis for adult use, saying revenue generated from the sector “might be one way” to bridge the state’s budget gap, WPVI reports. In a tweet, Wolf said cannabis-derived tax revenues should be used for small business grant funding and restorative justice programs.

The governor’s plan would see 50 percent of the small business grant funds used for historically disadvantaged businesses – those majority-owned by Black, Hispanic, Native American, or Pacific Islanders.

Last year, Wolf said it was “time to take a serious and honest look” at legalization following a report by Lt. Gov. John Fetterman which found the majority of Pennsylvanians supported the reforms.

Republicans in the state came out in opposition to the reforms following Wolf’s comments. Jake Smeltz, chief of staff to Speaker of the House Bryan Cutler, told PennLive that Cutler’s 2020-2021 legislative priorities do not include making sure “people can get high legally.”

House Majority Leader Kerry Benninghoff called the governor’s legislative agenda “disingenuous.”

Outgoing Democratic State Sen. Daylin Leach told WVPI that the state could begin seeing funds from the industry “right away” if legalization were approved from selling licenses.

“If we were to pass this in November I think by New Year’s we could have some product going out to people and we’ve seen during COVID crisis this is one of few industries that’s been doing much better than before COVID.” – Leach to WVPI

Wolf does not face reelection in November as his second term expires in 2022. Wolf approved the state’s medical cannabis law in 2016 and sales commenced in 2018.

In 2018, Wolf also approved an amendment to the state’s medical cannabis law allowing institutions to research the plant.

Republican members of the House said they have “no plans or interest” to support a legalization bill introduced in the chamber last year.

End

Vermont Lawmakers Close to Finalizing Expungement Reforms

8/26/2020

by

Vermont House and Senate leaders are set to pass a measure to automatically expunge criminal records for possession of two ounces or less of cannabis, VT Digger reports. The plan would also decriminalize possession up to two ounces – currently, only possession of up to one ounce is legal under the state’s legalization law.

The proposals would effectively expand the state’s legalization law and comes as the Legislature is attempting to come to an agreement on a deal to allow taxed-and-regulated sales which were not included in the 2018 reforms.

Rep. Maxine Grad (D), the chair of the House Judiciary Committee noted that people of color are disproportionately harmed by cannabis charges. Following the passage of the adult-use law, Chittenden and Windsor counties held “expungement days” to help people complete petitions to wipe the cannabis-related charges from their criminal records.

“Criminal records are a barrier to employment, serving in the military, student loans, housing, and it’s very important to help folks with these criminal records get justice and clean their records.” – Grad to VT Digger

Sen. Dick Sears (D), chair of the Senate Judiciary Committee called the reforms a priority. House Speaker Mitzi Johnson (D) – who has so far impeded progress for rolling out a cannabis marketplace in the state – said she is “totally supportive” of the expungement measure.

Critics of the bill to create a cannabis industry in Vermont have said the measure does not go far enough in addressing the racial disparities of the ‘War on Drugs.’ Supporters of the bill contend that the law would require the Cannabis Control Board to prioritize licenses for minority- and women-owned businesses.

Earlier this year, both chambers approved a bill to legalize sales; however, lawmakers were unable to come to a compromise on a final version of the bill, which ultimately stalled its progress.

End

CBD Nation: A Documentary for Cannabis Rookies & Experts Alike

8/26/2020

by

The newly released documentary CBD Nation takes an objective, scientific look at cannabidiol, the molecule known colloquially as CBD. Much like this film, CBD is challenging how the world sees weed. Film director David Jakubovic of Mad Machine Films explained that when setting out on this project, even he didn’t yet understand the value of cannabis medicine. While filming the documentary, he said his own perspective shifted and he hopes the film can inspire that same change in others.

“If you can watch this as someone stigma-minded and have their mind changed as I did, I will have done something,” said CBD Nation director David Jakubovic.

While traveling to meet with medical specialists and researchers, Jakubovic was introduced to patients whose lives had been forever changed by the properties of the cannabis plant. Their stories aren’t necessarily the research-backed data that doctors need, but each patient’s testimony is integral to the progress of cannabis science. Jakubovic agreed and this shaped the direction for the documentary: ultimately, CBD Nation offers a balanced selection of patient testimony alongside the great minds of cannabis science and research. Though the film is packaged for someone who has not yet realized the medicinal potential of cannabis, it is thought-provoking even for those of us who have been advocates for some time.

Activist and industry pioneer Andrew DeAngelo shared his hopes for the film:

“I hope people will get motivated to create change by seeing the movie. Once enough people are motivated then change can be created, and access follows from that. We are still in the moment of creating enough change to allow legal models that allow for safe access for the people.” — Andrew DeAngelo, in a statement

The crew traveled the United States and to Israel, the hub of cannabis research, collecting information and interviews. Conversations with activists like Andrew and Steven DeAngelo, research icons like Dr. Raphael Mechoulam, PhD., Dr. June Chin, and more than 20 other physicians, specialists, and health practitioners are featured in the film. Each participant is a thread in the film’s goal of providing a real educational view of the Endocannabinoid System. Dense molecular talk is balanced by the stories of real patients whose lives have been changed for the better by cannabis medicine. These heartwarming stories were essential to telling this story, but Jakubovic wanted to center a sincere analytical explanation of CBD in the film.

“There’s so much out there in the culture where cannabis is a punchline. I realized that this should just be fully serious. The fact needs to be what’s fascinating here,” explained Director David Jakubovic.

Each interview or personal account builds an argument for cannabidiol as an essential molecule in the human system. As it says in the documentary, “Our bodies are built to consume cannabis,” but our medical community has not been trained for it. This ineptitude is the result of a government that is unwilling to recognize multiple studies showing the therapeutic benefit of cannabis medicine. CBD Nation displays just the facts in the hopes that a concise, objective delivery of information can shift the societal stigma around cannabis and CBD.

I can recommend this documentary for everyone, from the staunch anti-marijuana club to the loud cannabis activists. Many cannabis books and films have fallen short of providing keen insight into this fascinating field of scientific study — in the case of CBD Nation, however, I found myself learning about concepts that are familiar to me in a digestible way and which allowed me to sharpen my understanding, even after almost a decade in the cannabis industry.

End

Kamala Harris Says Biden Admin Will Decriminalize Cannabis

8/25/2020

by

The Biden Administration would pursue policies to decriminalize cannabis possession and enact some police reforms, said Sen. Kamala Harris (D-CA) — Joe Biden’s pick for vice president — in an interview yesterday with ABC News.

During the interview, Sen. Harris was pressed about her prosecutorial and pro-law enforcement background. She said that the Black Lives Matter movement, which was once again spearheaded into the global spotlight following the May 25 police murder of George Floyd, has changed the conversation and is an important “counterforce” to the American status quo. She described plans to investigate police departments with a “history” and “pattern” of discrimination, and said the ticket will pursue a “policy that is going to be about decriminalizing marijuana.”

The Biden campaign said in May that his “Plan for Black America” included cannabis decriminalization policies and the expungement of cannabis convictions.

Meanwhile, a task force comprised of members from the Biden campaign and from Sen. Bernie Sanders’ (D-VT) presidential campaign sought to soothe tension between Biden and the party’s more progressive wings. That coalition ultimately embraced cannabis decriminalization reforms but — like Biden himself, who until last year said he still considered cannabis to be a gateway drug — stopped short of endorsing full legalization.

Since being elected to the Senate, Sen. Harris sponsored the 2018 MORE Act, or Marijuana Opportunity Reinvestment and Expungement Act, which would have federally legalized cannabis and reinvested the proceeds into supporting over-policed communities.

“Times have changed — marijuana should not be a crime,” she said then. “We need to start regulating marijuana, and expunge marijuana convictions from the records of millions of Americans so they can get on with their lives.”

End

Mitch McConnell Recommends Hemp-Based Face Masks

8/25/2020

by

Senate Majority Leader Mitch McConnell (R-KY) has suggested that Americans wear hemp-based face masks to prevent the spread of COVID-19, Marijuana Moment reports. The statement came during a news conference held at the Kentucky hemp company Ecofibre, which has been producing hemp-based face masks amid the ongoing pandemic.

Sen. McConnell highlighted Ecofibre as an example of how Kentucky businesses had “adapted to the pandemic situation” to produce “helpful” products.

“The coronavirus is not gone. In the meantime, I recommend a hemp mask as one of the best.” — Sen. Mitch McConnell, in a statement

Sen. McConnell has been a vocal supporter of industrial hemp for several years and spearheaded the push to federally legalize hemp via the 2018 farm bill. He symbolically signed his name on that bill with a pen made from hemp.

While bullish on hemp, however, the Senate Majority Leader remains a marijuana skeptic. Earlier this month, he goaded House Majority Leader Nancy Pelosi (D-CA) over language in the House coronavirus relief plan that seeks to give the cannabis industry access to traditional banking services. Sen. McConnell suggested that the cannabis provisions were “strange new special interest carveouts” that were unrelated to COVID-19, despite the industry’s nearly universal status as an essential service throughout the pandemic.

End

Oklahoma Testing Lab Investigated Over Falsified Results

8/25/2020

by

Oklahoma officials have confirmed that F.A.S.T. Laboratories, headquartered in Oklahoma City, is under investigation following allegations that the lab falsified cannabis product test results, according to a Tulsa World report.

Terri Watkins, Director of Communications for the Oklahoma Medical Marijuana Authority (OMMA), said in the report that F.A.S.T. Labs and its owner Kyle Felling were subjects of pending investigations by the OMMA and the Oklahoma Bureau of Narcotics and Dangerous Drugs (OBNDD) but would not offer more information. Mark Woodward, Communications Director for OBNDD, similarly deflected, saying “OBN isn’t in a position to discuss the actions of our agency regarding FAST Labs.”

F.A.S.T. Labs’ owner Kyle Felling told the Tulsa World that he was “aware of a complaint” and that he was cooperating fully with the state’s medical cannabis regulators but would not offer further comment due to the investigations’ ongoing nature.

F.A.S.T. Labs is one of nearly two-dozen testing labs approved for Oklahoma’s medical cannabis industry. Under Oklahoma’s medical cannabis rules, all products must be tested and approved by a state-licensed laboratory as of July 1.

Medical cannabis was first made available for purchase by patients in 2018.

A petition to legalize adult-use cannabis in Oklahoma was underway earlier this year but that effort halted amid a stay-at-home order and social-distancing guidelines laid out by Gov. Kevin Stitt in response to the pandemic.

End

Trump Worried Cannabis Votes May Lose Him the Election

8/24/2020

by

According to a Daily Beast report, President Donald Trump (R) is concerned that cannabis legalization voter initiatives could “supercharge turnout” by voters who support Democrats in the upcoming election.

One GOP strategist told the Daily Beast that Trump is “keenly aware of how presidential elections … can be won at the margins.”

“The pot issue is one of many that he thinks could be a danger… He once told me it would be very ‘smart’ for the Democrat Party to get as many of these on the ballot as they could.” – Republican strategist to the Daily Beast

During the 2016 campaign, Trump indicated he would allow states to determine their own cannabis policies; however, as his Cabinet started to take shape following his election – including anti-cannabis zealot Jeff Sessions as his first attorney general – the administration would take a more hardline stance, such as rescinding Obama-era policies protecting legal medical cannabis programs.

Following the 2018 midterm elections – which gave control of the House of Representatives to Democrats – California Sen. Dana Rohrabacher (R) signaled that the administration was planning federal cannabis reforms. Those reforms never materialized.

In June, Attorney General Bill Barr was accused of weaponizing the Department of Justice’s Antitrust Division to investigate cannabis mergers due to his negative feelings about the industry.

So far, broad cannabis legalization initiatives have qualified for ballots in Montana, Arizona, and New Jersey, while South Dakota will vote on both medical and adult-use questions. Mississippi has approved a medical cannabis ballot initiative, while Nebraska advocates submitted signatures for its medical cannabis initiative for review last month, but they have not yet been approved.

Arizona will likely serve as a battleground state during this year’s election as Trump only won the state by 3.5 percentage points in 2016; he leads former Vice President Joe Biden by 8.4 percent in current state polling, according to FiveThirtyEight. In New Jersey, Biden is leading Trump 55.2 percent to 34.5 percent, while Trump is besting Biden by 11.7 points in Mississippi according to FiveThirtyEight data. Trump won South Dakota in 2016 by nearly 30 percentage points and 270toWin rates the state as “Safe Trump.”

Nebraska election polling since May shows Biden with a slight lead over Trump but the president won the state handily in 2016.

End

Poll: New Jersey Supports Legalization, Social Equity, & Consumption Lounges

8/24/2020

by

A poll from the Cannabis Law Practice of law firm Brach Eichler found 66 percent of New Jersians support broad cannabis legalization in the state, with 27 percent opposed and 7 percent unsure.

Last December, New Jersey lawmakers approved legislation that will see voters decide whether to enact the reforms in the Garden State in November, and the poll found 71 percent of respondents were aware of the impending vote while 29 percent were not aware.

A Monmouth University poll in April found similar support – 66 percent – among potential voters for the reforms, with 34 percent opposed.

A slight majority of respondents (55 percent) polled by Brach Eichler said recreational cannabis should be taxed at a higher rate than the current 6.625 percent sales tax, while 30 percent opposed a higher rate.

Charles X. Gormally, Co-Chair of the Cannabis Law Practice, said that while “most people don’t favor higher taxes,” the polling “reflects both an awareness of the fiscal needs of the State, as well as an understanding that other states that have legalized cannabis have imposed taxes and surcharges of up to 25 percent.” He added that voters polled want cannabis-derived tax revenues for drug awareness and education.

A strong majority of those polled indicated New Jersey’s cannabis industry should have a strong social equity component, with 74 percent saying officials should ensure minorities have fair and equal access to licensing; 12 percent were opposed, and 14 percent were unsure.

“This reflects the increasing national awareness and growing concern about how minority groups have been disproportionately impacted by the failed policy of cannabis prohibition. Meaningful minority group participation in the ownership of new cannabis businesses is a direct and credible way to address this longstanding social justice concern.” – Gormally in a press release

The survey found support for social-use lounges split 47 percent in favor to 41 percent opposed. A survey in July by the practice found 50 percent in favor with 39 percent opposed. Both polls found 12 percent were undecided.

New Jersians also narrowly supported municipal control over cannabis sales, 45 percent to 39 percent, with 16 percent unsure.

The majority of respondents from all political leanings supported the reforms, including 77 percent of Democrats (18 percent opposed), 56 percent of Republicans (37 percent opposed), and 58 percent of independents (32 percent opposed).

The poll was conducted by DKC Analytics and surveyed 500 registered New Jersey voters from August 5 to August 13, 2020. The margin of error is plus or minus 4.4 percentage points.

End

Unregulated Cannabis Sales Command 54% of Canadian Market

8/24/2020

by

Legal cannabis still comprises less than half – 46 percent – of all product sales in Canada nearly two years after nationwide legalization, according to Statistics Canada figures outlined by Bloomberg News. The sector is now worth $1.7 billion in the Great White North.

Canaccord Genuity analyst Matt Bottomley told Bloomberg that illicit sales still hold the majority of the national market share due to high prices which don’t give consumers “a lot of incentive” to make the transition to taxed and regulated sales.

Bottomley notes that in most legal cannabis markets, edibles make up about half of all sales but in Canada, where they were only made available last year, they are just 15 percent of the market.

A June report from Statistics Canada found that unlicensed producers and sellers in British Columbia made about one-third more in revenues in 2019 than licensed companies, earning $1.24 billion compared to $765 million. In the Northwest Territories, officials reduced the price of all cannabis products by 10 percent in an effort to combat unregulated sales.

According to the agency, cannabis sales rose 19 percent in March as the coronavirus pandemic spread throughout the country but Bottomley suggested there are “still a bunch of potential customers sitting on the sidelines.”

In all, since legal sales began in October 2018, legal cannabis sales have contributed $3.96 billion to Canada’s gross domestic product. Statistics Canada also reported that estimated illicit cannabis sales contributed $4.13 billion to the nation’s economy, down about 21 percent since the rollout of the regulated industry.

End

Noel and Graham Abbott: The Origin Story of Ganjapreneur

8/21/2020

by

Noel Abbott, CEO of Ganjapreneur, and Graham Abbott, our Chief Editor, are brothers native to the northwestern corner of Washington state who started blogging about cannabis in 2013. In 2014, they partnered with venture capitalist and digital-era entrepreneur Andrew Rosener to found Ganjapreneur.com, which has since grown into a multifaceted resource for cannabis professionals and is relied on for industry news by hundreds of thousands of people around the world.

Recently, Noel and Graham joined our podcast host TG Branfalt for a retrospective discussion about their backgrounds and Ganjapreneur’s origin story. This conversation reveals many behind-the-scenes details: from the website’s original conception after a long trek through Spain, to finding success as a fully-remote and digital-first publication, to why conducting business in the cannabis industry comes with a mandate of action against the many injustices of prohibition. They also talk about how witnessing repeated instances of “folly” in the industry led them to create Ganjapreneur’s latest project, Oregano.com, a cannabis satire outlet intended to raise funds and awareness for The Last Prisoner Project.

Listen to the interview below or via your favorite podcast app, or scroll down for the full transcript!

Listen to the podcast:

Read the transcript:

Commercial: This episode of the Ganjapreneur Podcast is brought to you by CannaPlanners. CannaPlanners is on a mission to normalize the emerging cannabis industry through beautiful design and professional web and marketing solutions. Whether you’re looking to create a new cannabis brand, improve your packaging design or get your company online. CannaPlanners has the perfect solution. Your website is the window into your cannabis company. Make sure that you look awesome, that your messaging is on point, and that traffic converts to customers through SEO. From CBD companies to dispensaries and everything in between, CannaPlanners has you covered. Visit them online today at CannaPlanners.com for a free web demo.

TG Branfalt: Hey there. I’m your host TG Branfalt. And thank you for listening to the ganjapreneur.com podcast where we try to bring you actionable information and normalize cannabis through the stories of ganjapreneurs, activists and industry stakeholders. Today’s kind of a special show, where I’m joined by the founders of Ganjapreneur, the Abbott brothers, Noel Abbott, who’s the CEO, and Graham Abbott, who’s the chief editor.

Before they introduce themselves and get in their background, I just want to tell a little story. I met these guys about six years ago, never actually met them in person, through a Craigslist ad. I had just covered the passage of medical cannabis in New York for Reuters. Was doing a lot of freelancing. And they were looking for a brief writer. And here we are six years later. We’ve never really discussed in public sort of our relationship and how Ganjapreneur works. So, Noel, Graham, how are you guys doing?

Graham Abbott: Doing great. This is Graham here.

Noel Abbott: Yeah, Noel here. Great. Doing well. Thanks for having us, TG. It’s been a long time coming.

TG Branfalt: Why don’t you guys just sort of tell everyone the stuff that I know a lot of but don’t know everything about your background. How’d you guys end up in the cannabis space and what’s it like doing this as brothers?

Noel Abbott: Totally. Well I guess I’ll jump in first, this is Noel. I guess to provide background on how we wound up here specifically with Ganjapreneur and sticking with it for so long, it would make sense to start with when we first had the idea of starting a project together of any kind. It was about eight years ago I think when Graham and I were on the Camino de Santiago, which is a trek in Spain. And this was right after Graham had graduated from college. And Camino de Santiago is a pilgrimage. I think it’s got Catholic background, and it’s about 500 miles total from start to finish. Yeah, it was a lot of walking. I didn’t do the whole thing. I met up with Graham at about the halfway point I think. Graham had just graduated college and I was, I still had a full time job at the time working for a software company.

I remember when I met up with Graham and the group that he was with at the halfway point, I walked into the town and they were sitting at this table having lunch at a terrace restaurant. And there was this woman at the table who was a venture capitalist, an angel investor. And she had already been talking with Graham and his friend who was on the trek with him about the idea of pitching her a company during the course of that journey. And Graham, do you want to, I don’t really have the background of that.

Graham Abbott: Well, yeah. I think she was looking for youngsters to invest in and grow her fortune. And she was really pushing for us to come up with that next big idea that she could invest in. So yeah, we kind of tossed some things around. I believe you were the one who actually talked to her first about the cannabis industry, Noel.

Noel Abbott: Right. That was after the trek had completed. I think it was a couple months later. We had originally mentioned the idea, we didn’t really have a fleshed out proposal for her but we had mentioned the idea of some kind of an app that would connect community gardens and organic farms and locally produced food with people nearby. And she didn’t really see how that was going to be very profitable. So we kind of left it at that. It was sort of a dead chain of emails for a while.

Then when Washington and Colorado first had their votes to create the adult use industries, I reached back out to her with a proposal for some ideas for a cannabis focused media project. And she just flat out rejected me and was almost, in fact, offended, I would have thought of her for that. But that really was what got us thinking about just the possibility of creating a project that we could use to sustain ourselves and sort of determine our own career trajectories. So I’ll credit her with planting that seed in our brains because neither one of us really had thought about that as a potential direction for a project.

TG Branfalt: And what about you, Graham? Noel was doing software stuff. What were you doing prior to graduating college and shortly thereafter, it appears, starting Ganjapreneur.

Graham Abbott: In college, I studied communications. And then after graduating, I left and went on that trip. For me, it started as just that pilgrimage, just kind of an experience. And then I ended up staying in Europe. And then when my visas had run out there, we went over to Southeast Asia. I ended up on a long year tour around the world and then came back and was looking for something to do. That very first summer I came back, I was canvassing for a little bit, that kind of got me into the political sphere. But then I ended up, it was right when I had quit that job was when Noel started talking to me about the idea of writing on a semi-regular basis about this budding industry. We were certainly really excited about the industry, about legalization in general and we’ve been supporters of the movement since, I can’t speak for Noel, but for me, it was in college was where I came around to cannabis. In high school, I wasn’t a narc, but I was pure you can say.

TG Branfalt: Why the media space? You have this background in sort of software and communication. I obviously ended up in the cannabis media space, but didn’t found a media company. So first of all, why did you guys decide the news and then sort of media side of it? And then sort of describe going from this little blog to hiring writers and becoming sort of a mainstream source.

Noel Abbott: Totally. So, at the time that I had first reached out to Graham about starting a project, we had a few different ideas that we were throwing around. There was an idea to offer marketing services and web development services because that was really my career focus at the time to retailers and manufacturers as they started opening up. And we did pursue that a bit, and I still am a partner in a small creative agency that I started with some friends a few years prior to that that never really became our full-time focus. But it’s been something that has continued on.

And so, that was one angle. And the blog concept was really just to establish presence at the beginning, to have a place where we could publish things on a regular basis. It seemed obvious that people were going to be interested in keeping tabs on the industry as it developed. Granted there were already a lot of cannabis oriented publications out there, but not very many of them focused specifically on the business side of the industry or the b2b angle. And so, that was our focus from the beginning was to talk about the entrepreneurs and the businesses that were starting up.

And over time, I think that that became our main focus just because, cannabis is a very volatile industry. There’s stories all the time about companies that came at the industry with a bunch of money and then wound up not hitting their benchmarks that they expected to hit, and then winding up getting acquired or gutted in some fashion. And with a media company, the business model works as long as there’s an audience. So, the volatility in terms of the changing regulations and competition and all of that, it doesn’t really affect us in the same way that it affects operators who are touching the plant.

I knew for our sake, also, both of us had writing backgrounds from our education and just hobbies. I think that’s why it really became our main focus and that’s ultimately why it wound up becoming the more successful idea of the several that we had started out with. And then over time, we never really had any moment of exponential growth. It’s always just been steady, hard work. And luckily, we’ve had the opportunity to partner with really talented people and to get really competent individuals on our team. And I really credit that as the most contributive factor in where we’re at today.

TG Branfalt: And Graham, what was the learning curve like for you? You had gone through a communications program, but you said that you didn’t really get into cannabis until college. You ended up being the chief editor. When I started with you guys, it was on a much smaller scale than it’s become. You were my point person for a long time, and it never really seemed to me that you were that new to this. It’s almost a surprise to me that you got sort of acquainted with cannabis later than a lot of people who would sort of end up in your role. So what was the learning curve like for you?

Graham Abbott: Well, it was steep. Honestly, it was a lot of fun at first. I knew my weaknesses going into it and just kind of devoured the news cycle for, I mean, I don’t know, never really stopped. It’s true, I didn’t study journalism specifically in school, and so I kind of had to embed myself into there and really try and learn as much as I could while participating in the industry kind of. Since the launch, things have gone well, for the most part. There were some hiccups. I’m glad to hear that you were unaware of my relative rookieness from the beginning.

TG Branfalt: Both of you guys, as leaders of this organization, neither of you have ever sort of, there’s never been this sort of thirst for power or sort of arrogance that comes with the role. Noel, when I started, I think you were technically the CFO.

Noel Abbott: I think I was the CTO.

TG Branfalt: CTO. That’s exactly what it was way back then. So tell me guys about sort of the experience building a brand from scratch, which you both sort of have that background in. And then tell me about doing it again with Oregano and the sort of endgame with Oregano. Talk about that a little bit too.

Noel Abbott: Sure. Before we get to Oregano, I’ll answer the question about how did we ultimately get to where we are in terms of going from the relative obscurity to being more of a brand and an established organization. I think that that really, that transition started when we first got connected with Andrew Rosener, who is the other official co-founder and the primary investor behind Ganjapreneur. At the beginning you said you found us through a Craigslist ad. Andrew also found us through the internet. And I had never met him when we first spoke. And we didn’t actually meet in person until well after we had been partnered with him on Ganjapreneur. I think it was like over a year later.

Graham Abbott: Cannabis Cup.

Noel Abbott: That’s right. At the High Times Cannabis Cup on April 20th.

TG Branfalt: Sorry to interrupt, but that’s still the craziest thing I’ve ever done that this job has afforded me was the Michigan Cannabis Cup. It’s a dream come true.

Graham Abbott: They’re wild places.

Noel Abbott: I haven’t been recently, but the one that we attended was definitely, that was the first time I’d ever been to any cannabis event and it was also the very first after the opening of the adult use markets in Colorado. And I was still full time employed as the marketing director for a software company at the time. So I had to tell them a lie and say that I was going camping for the weekend with my brother, but really we were going to meet the investor behind our cannabis industry startup that ultimately I wound up leaving them for. It was definitely an eye-opening experience. And when we did meet Andrew, it was  awesome, we actually didn’t get to hang out with him for very long because he wound up babysitting the cast of Super Troopers who got too high on dabs at the event.

So we only got to hang out with Andrew for like an hour, but I could just tell that he was as excited about the project as we were. It seemed like the focus was just on the incredible opportunity of being a part of history and being a part of this massive change in society that was going to be slow, but is hopefully a sign that there’s going to eventually be a world where cannabis is not demonized and criminalized and people don’t have to be locked up in prison for doing something that doesn’t harm anybody. Now there’s still people locked up in prison for nonviolent cannabis offenses. And that kind of brings us to the project Oregano.com which we had started planning last year.

And to get into that, basically, the context, I guess I didn’t fully explain Andrew and his role. When we first partnered with Andrew, the deal was he owned Ganjapreneur.com and we were currently operating on a different domain name. It was something like theganjapreneur.us. And he had the same idea for a brand and had reserved this domain much earlier. He reached out to us and he liked what we were doing and wanted to partner with us and have us use his domain. He would fund the company and we would all be partners.

So, fast forward five years, five and a half years to 2019 when we’re pretty well established, Graham and I had talked about the idea of doing cannabis industry satire.

Graham Abbott: We tried a few times too.

Noel Abbott: Yeah, we tried through Ganjapreneur on April Fool’s Day and things like that.

TG Branfalt: People get really upset.

Noel Abbott: Yeah. It’s the whole fake news thing, because people don’t read disclaimers or take away the obvious conclusions from a headline that’s clearly false. If they don’t get that right away, then they’re very upset. So, it makes sense to separate satirical content from editorial content. I agree with that 100%.

So, Oregano was an idea that we had. I realized that Andrew also owned oregano.com, the domain name. He is in fact, one of the most prolific domain name brokers and investors worldwide. And there’s this whole industry of aftermarket domain names that Andrew is repeatedly and continuously awarded as one of the top people in that industry. And he’s been around for a long time so he’s been acquiring really valuable domain names for a long time. And I pitched the idea of using Oregano as a satirical outlet for the cannabis industry. He was on board with it immediately.

And the reason why I think we felt the need for satire in the cannabis industry was specifically because after being around for so long, we had witnessed so much of what I guess I would only describe as folly. Just people with a lot of money coming to the industry assuming that everything’s going to work out fine, assuming that they know the audience that they’re trying to reach and just falling flat. And it happened over and over and over over the course of the past five or six years.

So, we definitely had, I would say some apprehension or annoyance about certain things in the industry and we wanted an outlet for that, so that we could hopefully produce something that’s going to entertain the people in the industry who have been around for a long time who’ve seen all the struggles of the industry. We wanted it to be something that wasn’t just going to be purely for entertainment’s sake because you can’t really separate cannabis from its history and the context of prohibition and the massive amount of injustice.

So, we decided to partner with an organization called The Last Prisoner Project. And their mission is to bring restorative justice to people who have been affected by the drug war, specifically people who are in prison for drug related offenses. So the idea was we would launch this satirical outlet, and at the end of every article it would have a disclaimer along the lines of, this article is a joke, but you know what’s not a joke is that there’s still 40,000 people behind bars for non-violent cannabis infractions.

TG Branfalt: So since the death of George Floyd, that that was about a month ago now, 50 something days ago, I think it is, 56, maybe 57 from the time that we’re recording this, we as an organization, it’s sort of the direction of you guys, have sort of brightened the spotlight on social justice aspects of prohibition. We’ve always covered the social equity stuff because we’ve always had sort of a very heavy business focus. There’s an obvious answer to this question, but why have you guys decided to put a bunch more emphasis on this issue collectively? You guys steer the ship. Let’s just be honest. If you read the comments, we post some of the social justice stuff, and we get laugh reacts for it. Seriously. I just want to point that out to listeners.

Noel Abbott: To fully answer that question, the timeline with Oregano was we had planned to launch it on April 1st because of April Fool’s Day and satire. And it was in March that the coronavirus pandemic started to really take off. And the Last Prisoner Project who we were working with reached out to us and said, “Hey, we’re afraid that if we don’t act soon that the people that we’re trying to save and to grant clemency for are going to be trapped in prison as this virus makes its way through the prisons.” And so, they wanted to get the word out as soon as possible because it was also an opportunity to put pressure on the government to actually get something done.

So we launched Oregano early. It wasn’t quite finished but we had launched the platform. And then over the next month or two, the pandemic continued to spread. Some jurisdictions have granted clemency to prisoners but it’s really nowhere near the amount that we would need to actually achieve some semblance of restorative justice. But then after the death of George Floyd, I just sort of had realized that over the past several years while we have focused on social equity in the states that have opened up adult use markets, I’ve always said that we want to reflect diversity in the people who we profile, we really weren’t putting very much of a conscious effort into accurately communicating the true depth of how just absurd the injustice is surrounding cannabis prohibition and how cannabis prohibition and the enforcement of it has tied into institutional racism and has really just decimated communities that are over-policed.

It also wasn’t just up to me and Graham. I would credit a lot of that shift in direction of our reporting to the women that we have hired. Ellie, who we hired just over a year ago, year and a half ago, when she came on to help us with social media, she told me that she wanted to focus on social justice with the accounts that she was choosing to highlight and to repost from. She pointed out that we weren’t doing very much with that. And I said, you know what, you’re right, let’s do it. And then after the death of George Floyd and all of the protests all over the country, I think a lot of, I mean, I hope, and I’ve witnessed it, so, I wouldn’t just say hope, but I hope that all white people are thinking about this at least. But as you mentioned, yeah, there are definitely people who think that it’s all part of some media manipulated narrative, and that it’s all a conspiracy.

TG Branfalt: So let me play devil’s advocate for a second. Graham, do you think that, we call ourselves, we are a b2b publication, do you think that it runs against the mission of being a business-focused publication to put more emphasis on the social justice aspects of prohibition?

Graham Abbott: No. Short answer, no. I’m not a cannabis business operator myself, obviously, but I do owe my livelihood to the industry. And the bottom line is that any person or any entity that’s benefiting from the cannabis space is implicitly benefiting from the painful history that cannabis has undergone, because the only reason why there’s this new exciting industry right now it’s because it’s been tamped down for so long. And so many people have been oppressed in the name of making this glorious new industry. It’s not enough for current business owners to just be sad for the people who have been locked up for decades. You can’t just say like, yeah, that sucked, but things are better now and we’re taking our own opportunities. Everything is tied back to that painful history. And there needs to be action from members of the industry, and to not act is … it’s morally unacceptable.

Noel Abbott: There’s an interesting parallel there with the existence of institutional racism as a whole. It’s like a conveyor belt that moves in one direction. And if you’re not doing anything, then you’re still moving with the conveyor belt. You actually have to make an effort to work against the current in order to have any effect. And there’s no such thing as neutrality, you can’t just remain apathetic to it. By doing so, you’re implicitly choosing the side of the status quo.

TG Branfalt: We’re talking about sort of the changes of the social order in some ways and how it relates to sort of what we do. So, I just want to ask sort of briefly the future of sort of cannabis industry publishing, especially in the era of COVID. I mean, we have worked remotely from the jump. I’ve worked in three or four different states while working for you guys. I think Graham’s done some publishing from Paris, France, or at least somewhere.

Graham Abbott: Yeah. Southern France. Was there for a summer.

TG Branfalt: So in the era of COVID, what do you guys see sort of as the future of the cannabis industry publishing and just sort of briefly talk about High Times and how their IPO has, what that sort of means it because it’s stalled and it hasn’t done the numbers that they thought it would. In the meantime, they’re buying a bunch of brands and touching the plant. Talk to me about sort of what you guys see the future of industry publishing at large, especially again, seeing what’s happened with High Times.

Noel Abbott: So I think the current state of cannabis media is in a kind of a precarious position because so many media companies, especially in the cannabis industry, have focused on the combination of print and events. And both of those are more difficult, events much more so, in the world of the coronavirus. I think High Times, whether or not they were going to have to close down publications just due to the need for revenue prior to the spread of the pandemic, is its own question. But obviously, with the coronavirus, the business model of hosting big events on a regular basis just becomes really, really difficult. There’s no clear end in sight at this point.

So, the companies that have relied on that, I think they’re having a hard time. I think that print specific publications are probably overall going to be fine. Even though we have seen numerous cannabis publications get closed down, there are also people who are doing really awesome things and who are setting a great example for the industry as a whole. Some companies that I would name in that regard are the Northwest Leaf. They have been expanding and they actually hired a bunch of the High Times writers who got laid off for their newest expansion in the north east. There’s a magazine called Broccoli Magazine, which is entirely women led and created. And that’s a really awesome artistic focused cannabis magazine, and I really love what they’re doing. There’s other industry publications like Marijuana Venture. I have a sense that all of these companies are going to be fine just because their audience still wants them around.

For us, I think that the coronavirus, because we’re a digital-first company, we’ve always been a remote company, we’ve only ever created digital offerings, we don’t host events, we don’t print magazines. For us, the impact of the coronavirus has really been pretty minimal. I think for niche publications in other industries, that might not be the same. But in the cannabis industry, we’ve seen cannabis be deemed essential in pretty much all of the states where it’s been legalized. And there’s clearly a high demand for cannabis during this time where people are stuck at home and they’re stressed out. It’s just natural that people are going to spend some of that time consuming cannabis. I think it’s healthier than if they were drinking.

So, in the long run, after, where we’re at, four months, four months later from when we kind of went into lockdown, it doesn’t really seem like the effect on the economy is really having the same effect on us. I think that hopefully cannabis media will be able to sustain, and all of these companies that are producing great content and employing people will be able to tough it out and make a resurgence after there’s some return to normalcy.

TG Branfalt: What’s your take on that, Graham?

Graham Abbott: I feel like that sums things up pretty nicely.

TG Branfalt: When the virus hit, for example, as sort of the chief editor, do you think that overall, the industry did well sort of with how it covered the coronavirus, because at the onset, I’m sure you were too, we were getting bombarded with sort of, what do I want to call them, snake oil salesmen, saying that, “oh, my cannabis product is going to save you from the coronavirus.” Do you think that the publishing side of the industry did well in not sort of biting on those duplicitous claims of fly by night companies?

Graham Abbott: I’d say for the most part, yes. I think publishers have been fairly responsible in that. I know there have been, so, obviously there are so called snake oil pushers who are, this was the case before COVID-19 with certain “bad players.” The CBD industry specifically.

Noel Abbott: We had a whole section planned on Oregano that was just about CBD infused products, like CBD infused shoelaces, CBD infused washing machines. There’s been a lot of those.

Graham Abbott: We’re guilty ourselves, we’ll talk about the latest, I think we ran an article about CBD infused sportswear at one point. And certain things are just so eye-catching. It deserves some mention just for how out-there it can be.

TG Branfalt: Well, I think it depends on how you cover it.

Graham Abbott: Exactly.

TG Branfalt: I think that’s been one of the sort of, the good things about having sort of you both at the helm in that you’re steady. It’s not like we cover it and make a big deal about it. We just want people to know like, hey, here’s the information, but we’ve never editorialized too much.

Graham Abbott: Yeah. On occasion.

TG Branfalt: When I go Gonzo and do too many dabs in Michigan.

Graham Abbott: There have also been these stories popping up about unverified studies investigating cannabinoids and terpenes and their potential effectiveness against certain symptoms of COVID-19. And those, we always have to preface that with this is a non peer reviewed, this is a pre-published article. Because the situation is evolving so rapidly, I think it’s still an important conversation or an important topic of conversation.

Noel Abbott: And it’s clear. I mean, it has been clear for a long time that cannabidiol is a very efficient effective reducer of inflammation. Just from anecdotal evidence, everybody that I talk to who use it says that. My personal experience of that. And there’s medical research that shows that. So I don’t think it’s completely outside the realm of possibility that it’s a viable treatment for alleviating symptoms. If that’s possible and it’s being held up by the current state of regulations, I think that it deserves more attention.

TG Branfalt: And I’m actually sitting here with the half injured shoulder, we’ll call it, and it’s covered in CBD and I feel great. The last couple of minutes here guys, give me some advice. What would you tell an entrepreneur about building a brand, because I think that that’s something that you guys have collectively done really, really successfully. Just from the imagery to sort of the, the colors and the attitude of the brand. So what advice would you have for entrepreneurs specifically when it comes to brand building?

Noel Abbott: Sure.

Graham Abbott: I’ll go first real quick and just say I think consistency and don’t be in a race to do everything and all of it all at once. I think focusing and fine tuning and just staying consistent to your original idea and add some elbow grease and good direction and that’s probably a better recipe than most.

TG Branfalt: And maybe walk 500 miles on a pilgrimage before you launch a company.

Graham Abbott: I don’t know — if that’s something you’re into, I can highly recommend it.

Noel Abbott: I would definitely credit, I think that the success of our brand in a marketing context, I credit a lot of that to my business partner in the creative agency that I had co-founded before Ganjapreneur, Casey Burton, who now is our creative director at Ganjapreneur. And he really conceived of and designed the entire visual identity of Ganjapreneur as it currently exists. Prior to that, it was kind of a, we didn’t look bad, I would say, but we definitely looked a little DIY. It was just stuff that I had put together.

I think that if you have people with different perspectives talking about how things look and how they are experienced by a user, if it’s a website or whether that’s packaging, as long as you have people who have knowledge about design and branding weighing in on that conversation, then you’re headed in the right direction.

I think a lot of startup entrepreneurs wind up thinking of their visual representation and their branding as kind of an afterthought to their idea. And it’s something that they want to save money on. And so, you can go to Fiverr or you can go to like a logo competition website and just pay $100 and get 10 different “logos.” But the visual identity of your organization goes so much further than just the logo. It really all has to tie into one singular philosophy or ideology that carries through everything. And so, your color scheme, your typography, everything that exists in the real world like print and packaging along with everything on the internet, should all be consistent. And that doesn’t just mean putting the same logo on everything.

So having someone, whether that’s an internal employee, who you trust, or an agency that you work with separately to help you with that when you’re at the point where you can afford to do something like that, I would say is very important.

TG Branfalt: Before we go, I just want to sort of thank you guys for the last six years. It was funny the other day, I was going through my Facebook memories and I actually had mentioned, it was February 25th, 2014, was the first time that I ever wrote anything for you guys, which is bizarre to see that, like ahead of this. You guys have given me a lot of flexibility as a professional. You’ve always worked with me as I transitioned to teaching and sort of some of the other, some of the other things that I’ve gone through in the last six years professionally.

I really appreciate what you guys have done in terms of offering a really sort of, it’s a special sort of website I think and product that you offer people. And it’s definitely a representation of what you guys had in mind, at least for my estimation, six years ago when I met you. And one day, we’ll meet in person. A lot of people probably don’t know, we’ve actually never met in person. I’ve always stayed on the east coast and then the Midwest briefly. Maybe one day you guys can come kick into the mountains because I’m not getting on a plane anytime soon.

Graham Abbott: Road trip.

Noel Abbott: That sounds great.

TG Branfalt: So again, thanks for being on the show. That was the founders of Ganjapreneur, Noel Abbott, he is the CEO, and Graham Abbott, the chief editor. Thank you guys again so much.

Graham Abbott: Thanks, Tim.

Noel Abbott: Thanks for having us, TG. We appreciate you, man.

Graham Abbott: And real quick, just also a quick thank you to our audience. We never really get the chance to address them directly but it means a lot that people tune in and keep tuning in. And we’ll keep it up.

TG Branfalt: You can find more episodes of the ganjapreneur.com podcast in the podcast section of ganjapreneur.com, Spotify, and in the Apple iTunes Store. On the ganjapreneur.com website, you’ll find the latest cannabis news and cannabis jobs updated daily along with transcripts of this podcast. You can also download the ganjapreneur.com app in iTunes and Google Play. This episode was engineered by Trim Media House I’ve been your host, TG Branfalt.

End

Federal Lawyers Told to Avoid Drug Possession Prosecutions In Canada

8/21/2020

by

Federal lawyers in Canada are being directed to avoid prosecuting simple drug possession cases unless there is a major public safety risk, the CBC reports. Under the policy of Director of Public Prosecutions Kathleen Roussel, federal prosecutors would only pursue criminal charges in “the most serious cases.” Instead, attorneys would seek alternative measures, such as restorative justice, and Indigenous approaches to deter simple possession cases away from the criminal justice system.

Public Prosecution Service of Canada Spokesperson Nathalie Houle told the CBC that when deciding to “initiate and conduct any prosecution” attorneys “must consider not only whether there is a reasonable prospect of conviction based on the evidence available but also whether a prosecution serves the public interest.”

“For example, where the possession relates to a substance use disorder, prosecution should generally be avoided where the offender is enrolled in a drug treatment court program or a course of treatment provided under the supervision of a health professional.” – Houle via the CBC

The reforms come as legislative leaders reconsider national drug decriminalization. Last month the Canadian Association of Chiefs of Police called on federal lawmakers to decriminalize low-level possession of all drugs for personal use. CACP President Chief Constable Adam Palmer said that current drug possession laws have “proven to be ineffective” and do “not save lives.”

“Being addicted to a controlled substance is not a crime and should not be treated as such,” he said in an interview last month with the CBC. “We recommend that Canada’s enforcement-based approach for possession be replaced with a health-care approach that diverts people from the criminal justice system.”

In a letter to federal lawmakers last month, British Columbia Premier John Horgan said implementing the reforms would “reduce the systemic stigma associated with illicit drug use and support people to access the services that they need.”

Liberal MP Nathaniel Erskine-Smith, who has supported broad decriminalization, said he was “more hopeful” than he has previously been about the reforms being enacted.

In 2018, Canada legalized cannabis for adult-use, becoming just the second nation to federally allow taxed and regulated cannabis sales.

End

CannaCon South Cannabis Expo Coming Back to Oklahoma in September

8/21/2020

by

Oklahoma City, Oklahoma, August 19, 2020 – The seminal cannabis convention is coming back to Oklahoma from Monday, September 28 to Tuesday, September 29 at the Cox Convention Center. This CannaCon South will feature special safety precautions to ensure that those enjoying speakers and networking opportunities are doing so in a clean, safe environment.

CannaCon is dedicated to supporting emerging markets, and Oklahoma is home to a quickly growing medical cannabis industry. Each time the event series has come to the state, those interested in Oklahoma cannabis business impart keen insights into the prosperous industry. Chet Tucker from Arcadia Brands will be featured in this year’s series with wisdom on marketing and the benefits of corporate branding. Tracy Szerszen from Perry Johnson Laboratory Accreditation, Inc. will also give a seminar overviewing the ISO 17025 Requirement for Testing Laboratories providing an all-encompassing look at Oklahoma cannabis.

Organizers have taken multiple precautions including increased aisle size, hand sanitizing stations throughout the hall, and 8’ sidewalls separating the inline booths to accommodate patrons amid the COVID-19 pandemic. On top of these precautions, guests’ temperatures will be checked upon arrival so that no symptomatic attendees can enter. There will also be signage around the convention center that reminds people to keep 6 feet apart when possible. And lastly, to meet Oklahoma City and Cox Convention Center mandate it will be required that everyone in attendance wear a mask to protect each other.

“We are thrilled to be bringing CannaCon back to Oklahoma,” said Angela Grelle, CannaCon’s Director of Marketing. “With the unprecedented growth of the medical cannabis market in the state, Oklahoma has proven to be a powerhouse in the cannabis industry. The CannaCon team has loved being a part of the growing community.”

About CannaCon
CannaCon is dedicated to creating and strengthening lifelong partnerships within the emerging cannabis industry. It is our mission to provide a global B2B venue for cannabis businesses, marijuana entrepreneurs, investors and community partners to showcase industry products, people, innovations and technology. We are committed to cultivating business values within the cannabis industry through education and responsible community involvement.

Angela Grelle
Director of Marketing
(425) 791-4467 ext. 102
angela@cannacon.org

###

End

AAA Donates $100,000 to Fight Cannabis-Impaired Driving

8/21/2020

by

The motorist club AAA is providing more than $100,000 in grants to Illinois public safety, health, and law enforcement agencies and organizations to stem cannabis-impaired driving, WAND17 reports. The grant funding comes three weeks after the AAA Foundation for Traffic Safety released a report suggesting that more Washington state drivers involved in fatal crashes are testing positive for THC.

According to the study, between 2008 and 2012 – prior to broad legalization in the state – an estimated 8.8 percent of drivers involved in fatal auto accidents in the state. The AAA study found that rate rose to an estimated 18 percent post-legalization, from 2013-2017. The study also suggests that the average number of THC-positive drivers in fatal crashes increased from an average of 56 in the five years before legalization, to 130 in the five years post-legalization.

“AAA opposes the legalization of marijuana for recreational use because of its inherent traffic safety risks and because of the difficulties in writing legislation that protects the public and treats drivers fairly.” – AAA in a press release

The grant money will be used for Advanced Roadside Impaired Driving Enforcement, a program which teaches law enforcement officers how to identify and articulate the signs of impairment related to drugs and alcohol; for purchasing the ToxOptix X3, a pen containing a UV lamp, medical penlight, and a timing system for standardized sobriety testing; and Fatal Vision Marijuana Goggles.

Among the grant recipients are 24 police and law enforcement organizations throughout Illinois, three hospitals, public safety advocacy organization Alliance Against Intoxicated Motorists Organization, and two public health organizations.

End

Appeal Moves Forward in ‘Woodstock’ Cannabis Trademark Dispute

8/21/2020

by

The battle over the use of the “Woodstock” name for cannabis products is continuing in the U.S. Second Circuit Court of Appeals which heard that the U.S. District Court judge in the July 2019 ruling had erred in his decision granting the festival owner use of the moniker, Law360 reports.

Woodstock Roots LLC., and its affiliate Woodstock Products, argue that they secured trademark registrations to use “Woodstock” to sell non-cannabis smokers’ products – such as lighters and rolling papers – in 2013. They say the trademark filings predate the trademark attempt for cannabis products by Woodstock Ventures LC, the company that owns the rights to the 1969 festival.

In the 2019 ruling, U.S. District Judge Paul G. Gardephe said that while Woodstock Roots had obtained their trademark before Woodstock Ventures, the former company did not intend to use its trademark in the cannabis space. Woodstock Ventures has maintained that Woodstock Roots is violating its trademark by using the “Woodstock” name for branding. Woodstock Ventures’ co-founder Michael Lang plans to use the name for “Woodstock Weed,” which would use strains inspired by those available in the 1960s, like Panama Red and Acapulco Gold.

Woodstock Roots argues that Woodstock Ventures only “intermittingly” used the mark and presented “unreliable evidence” that it had previously used the mark for smokers’ products. Woodstock Roots also claims that Gardephe erred in his ruling that there would be no consumer confusion over the products – one for tobacco and one for cannabis – and, moreover, that cannabis products are federally outlawed and, therefore, cannot be trademarked.

Woodstock Ventures has applied to cancel Woodstock Products’ trademark registration for smokers’ articles, but the application has not been enforced pending the legal battle, which began in 2018.

End

Hempcrete: How Sustainable Construction Could Change the World

8/20/2020

by

European building projects have relied on hempcrete to construct insulating, non-weight bearing infill walls since the 1990s. In fact, the popularity of building with hempcrete grows year over year in France but, in the United States, a builder must acquire a special permit to work with the materials.

In Bellingham, Washington, one homeowner took on a project using hemp-lime and weighed in on the pros and cons of building a house with hempcrete. Pamela Bosch is in the process of renovating her 1960’s home using hemp-lime and has named the project the Highland Hemp House. She credits an intrigued Planning and Permit department worker and a town interested in sustainability for the ease of getting the proper permits for building. In fact, because the Highland Hemp House design was energy-efficient, Bosch’s permits were fast-tracked.

However, the process still wasn’t simple. Finding lawyers, builders, and other necessary ancillary contractors to work on a hempcrete project led to unexpected costs, much of which was due to a lack of understanding. Builders don’t know how to work with it, insurers don’t know how to quantify it, lenders can’t estimate it — the list goes on and on. Ignorance and unfamiliarity with hempcrete have led to disinterest from American building projects. It has also made things more difficult for private citizens who are interested in using the material in their own renovations or projects.

What is Hempcrete?

Hempcrete is a biocomposite building material made by mixing the woody inner lining of the hemp stalk (hemp hurds) with either lime, sand, or pozzolans. It can be found marketed under names like hemp-lime, canobiote, canosmose, and isochanvre. Many builders find hempcrete easier to work with than other lime mixes as it is not as brittle as concrete, and that is the first of many differences between the two building materials. Hempcrete also has just 5% of the compressive strength of residential concrete and 15% of the density of traditional concrete. Because of this, hempcrete walls must be supported by a frame made using a different material. This grants the benefits of hempcrete while still supporting a vertical load.

What Are the Advantages of Hempcrete?

There are many advantages to building a structure out of hempcrete. The composite building material acts as an insulator while also regulating moisture and humidity. The porous structure of the materials and the alkaline property of the lime contribute to this effect. It can also absorb excess moisture from the air when humid to cut back on the risk of mold spore formations.

Some reports also suggest that hempcrete could be fire-resistant, and it is a certified fire-proof building material in France and the UK. However, metrics system-based tests and data have been widely ignored in the States. Many building inspectors hesitate to grant permits to build the lime composite material. Sources also state that hempcrete is pest resistant, though the source data for these claims haven’t been located.

One very attractive advantage of building with hempcrete is how sustainable the material is — it is carbon-negative. In fact, during the growth of the plant, hemp will absorb so much carbon that more CO2 is absorbed in a hempcrete wall than is used in the entire process to build it. It can also work well combined with original materials when fortifying historic buildings. And as it ages it will turn to petrified rock, so in the best case, the structure could last hundreds of years.

Thermal insulating hemp fiber panels, another highly sustainable hemp-based construction option.

What Are the Disadvantages?

There are some real challenges to working with hempcrete. It has about 1/20 the strength of concrete and, because of this, a structure built with hempcrete requires a timber frame made of steel or concrete to support the load of the house. This is one place where Pamela Bosch and her Highland Hemp House hit trouble. Her town of Bellingham is in a challenging seismic zone for building, and hempcrete is not yet ICC (International Code Council) ASTM (the American Society for Testing and Materials) certified. To compensate, Bosch had a stand-alone internal framework engineered, an expensive setback.

The hemp advocate also had to finance the project herself and take on all liability with the city, and high startup costs are very common when building a hemp house. Without any prior experience with hemp structures, banks and insurance companies would not support the Bellingham building. Complications due to inexperience are also common in the engineering and building process. Some hemp projects have hit major complications when builders treated the material like traditional concrete. With how rarely hempcrete has been used in construction projects, there really isn’t much experience to pull from.

Where do you get the hemp?

Hemp production has picked up in the United States, but many of the plants are grown to be manufactured into CBD oil. These plants are generally more knobby and less ruddy, which isn’t ideal for making hemp hurds. Even if farmers got on board growing different varieties of hemp, there isn’t any infrastructure in place to process the materials. For the Highland Hemp House, Bosch shipped a 40’ container of hemp hurd in from the Netherlands, which doubled the cost of the materials.

She explained that despite the doubled cost, it was a small fraction of the building process.

“Of more consequence was the time, effort, and expense of breaking with the status quo,” Bosch said. “Contractors, engineers, plumbers, electricians, city attorneys, insurance companies, (and the DEA), generally had to be persuaded that it would not be too painful to try something new. The braver and more philosophically inspired were among those I was able to contract, but the novelty also generally accrued a fee.”

Some will look at the positives and negatives of building with hempcrete and agree that the building material is worth exploring, but what will it take for the United States to accept hempcrete? More research. Bosch’s project makes it clear that bias is one of the biggest hurdles in projects like the Highland Hemp House, and supportive research is the best way to sway bias. American architects and engineers are currently only taught how to work with wood, concrete, and steel. Research-supported data could shake up the curriculum and drive more brilliant minds to better figure out hempcrete construction projects.

End

This County Will Let Cannabis Arrestees Get a Medical Card to Avoid Jail

8/20/2020

by

New rules by Maricopa County, Arizona Attorney Allister Adel will allow anyone who gets arrested for simple cannabis possession to apply to the medical cannabis program and get a card to avoid prosecution, the Phoenix New Times reports. Under state law, any cannabis offense is a felony.

“In cases where the defendant was not in compliance with the AMMA [Arizona Medical Marijuana Act] at the time of the crime solely because the person did not have a valid medical marijuana card, [Maricopa County Attorney’s Office] will dismiss a charge involving any crime covered by the AMMA if the defendant obtains a medical marijuana card and provides proof by the [initial pretrial conference hearing].” – MCAO Prosecutions Policies and Procedures

Pretrial conference hearings can be scheduled up to 45 days after an arrest, which leaves the accused some time to get a medical cannabis card – which cost between $250 and $300. That state’s medical cannabis law allows patients to possess up to 2.5 ounces of cannabis, along with any paraphernalia they required to store or ingest it. People who live 25 miles or more from an operating dispensary are allowed to grow up to 12 plants in their home.

An American Civil Liberties Union report published last month found that Hispanic people in Maricopa County charged with simple possession are sentenced to significantly longer jail and prison terms than their white and Black counterparts, and that Black people convicted of personal possession of drug paraphernalia receive longer sentences than whites and Hispanics.

Maricopa County garnered national headlines for institutional racism under the direction of former Sheriff Joe Arpaio. The former sheriff was convicted of criminal contempt of court after refusing to stop racially profiling people when detaining “individuals suspected of being in the U.S. illegally.” Arpaio was pardoned of that crime by President Donald Trump in 2017.

In November, Arizona voters will decide whether to legalize cannabis for adult use. Voters rejected the reforms 52-48 percent in 2016. A June 1 poll of 400 likely Arizona voters conducted by HighGround Public Affairs Consultants found 65 percent supported the reforms (47 percent “definitely yes,” 18.5 percent “probably yes”) compared to 22 percent who said “probably” or “definitely” no.

End

New York Won’t Submit Hemp Plan Until USDA Loosens Rules

8/20/2020

by

In a letter to industrial hemp growers last week, New York Agriculture and Markets Commissioner Richard Ball said officials do not plan to submit a state plan for the 2021 growing season unless the U.S. Department of Agriculture changes certain program requirements.

If New York does not submit a hemp plan to federal regulators, hemp growers in the state would need to apply to the USDA’s Agricultural Marketing Service for a producer license. In 2019, more than 500 producers and over 20,000 acres were authorized to cultivate hemp in the state.

In the letter, Ball described federal hemp testing and plant disposal regulations as “unrealistic” and said they, “impose unreasonable burdens on growers and any state interested in administering a compliant program.”

“Please understand that the State will continue to advocate for reasonable requirements related to the oversight of industrial hemp. In this regard, the Department has asked the USDA to extend the 2014 Farm Bill until 2021 and to otherwise provide a more flexible regulatory structure. We have made clear that if the federal requirements are modified to remove the challenges communicated to the USDA, the Department will reconsider submitting a state plan to assume responsibility for the program.” – Ball in the Aug. 14 letter

Prior to the passage of the 2018 Farm Bill, which legalized hemp federally, individual states operated their own hemp cultivation programs free from federal interference under a 2014-approved plan.

According to a USDA comparison of those two programs, the 2018-approved rules require “a representative sample” of the crop is tested by a Drug Enforcement Administration-registered lab “within 15 days prior to the anticipated harvest.” Under the previous rules, testing requirements were set by the states and didn’t require labs to be DEA-registered. The rules also require non-compliant plants – meaning they are over the 0.3 percent THC threshold – to be destroyed “using DEA and [Controlled Substances Act] procedures.” Previously, those rules were set by the state.

The old rules also didn’t require sharing of information with law enforcement and allowed states to set the rules for which products could come to market.

Under current rules, federal hemp licenses may be issued to cultivators and processors in states that do not regulate hemp but do not specifically outlaw it. Native American tribes living on sovereign lands in states with hemp bans may also apply to the federal government to grow and process hemp. Producers in states without legal hemp are not eligible for USDA licenses.

End

ParagonCoin Couple Can’t Be Located by Courts as Legal Woes Mount

8/20/2020

by

The couple behind ParagonCoin, promoted as the cryptocurrency for the cannabis space launched in 2017, have failed to appear in court and cannot be located by the courts, according to a Coin Desk report. Jessica VerSteeg, a former Miss Iowa, and her husband, Russian entrepreneur Egor Lavrov, are being sued over the token sale with plaintiffs asserting that it was an illegal securities offering and that buyers are intitled to refunds or compensatory damages.

In 2018 – about a year after the coin’s launch – the company was fined $250,000 by the Securities and Exchange Commission and ordered to repay the investors of the initial $12 million coin offering. Following the fine, the company put a building up for sale it had planned to use as a co-working space paid for with the token. It’s unclear whether the company paid the SEC fine in full; a 2019 Wall Street Journal report suggests the company missed payment deadlines.

The couple has so far failed to appear at any of the legal proceedings in the Northern District of California. Attorney Donald Enright, who represents the plaintiffs, told Coin Desk that the couple’s attorneys “have withdrawn as counsel.” Plaintiffs are seeking to have the case turned into a class action.

The defendants’ former counsel, attorney Howard Schiffman, said that he hasn’t seen the couple in “years.”

In addition to the VerSteeg and Lavrov, the lawsuit names The Game – the rapper whose real name is Jayceon Terrell Taylor – due to his role promoting the initial coin offering on social media. Technologists Eugene Bogorad, Alex Emelichev, Gareth Rhodes, and Vadym Kurylovich are also named as defendants.

Bogorad told Coin Desk that most of the people named as defendants don’t consider themselves company founders and they only worked on the project in 2017, while VerSteeg promoted the coin throughout 2018.

End

Biotech Firm: Fermentation-Based Cannabinoid Production Ready for Industrial Scale

8/19/2020

by

Lygos, Inc. — a full-stack provider of sustainable specialty ingredients meant for cannabinoid-based consumer, nutraceutical, and pharmaceutical products —announced in a press release this week it had finalized a novel process of creating cannabinoids with proprietary fermentation and processing technology.

The process will enable the industrial-scale production of “any cannabinoid and cannabinoid-based product of interest” in a safe, sustainable, and cost-effective manner, the company stated.

The development resulted from Lygos’ February acquisition of Librede, Inc, a synthetic biology company specializing in cannabinoid products.

“We couldn’t be more pleased at the speed with which the Librede and Lygos teams integrated efforts and technologies despite the global pandemic and shutdowns,” said Eric Steen, CEO of Lygos.

“These rapid advances have accelerated our timetable for forming partnerships and delivering new cannabinoid-enabled products into the market. By delivering high quality, pure and sustainable cannabinoids at commercial volumes and competitive prices, we are poised to rapidly enter high-growth consumer market segments with Lygos branded or co-branded products by capitalizing on the expertise and reach of our strategic partners.”  — Eric Steen, PhD, CEO of Lygos

In 2019, synthetic biologists at the University of California, Berkeley successfully extracted cannabinoids from brewers yeast. Those cannabinoid extractions included THC, CBD, and others not found naturally in the cannabis plant.

End

Portland, Oregon Seeing Spike In Dispensary Break-Ins

8/19/2020

by

Portland, Oregon cannabis dispensaries have been the target of at least 47 break-ins since late May, according to a Willamette Week report. At that rate, dispensaries in the city are targeted by break-ins on every other night.

Three of the store owners told WW that they were victims of armed robberies, including one in which the employees were held at gunpoint and were bound with zip ties.

The Oregon Liquor Control Commission says that over the last three months, 60 dispensaries have reported lost product, totaling $135,000 in June alone. Portland Extracts owner Jordan Jacobsen told WW that his shop was hit in August and the robbers stole $200,000 worth of product.

Amberlight Cannabis House manager Camille Farrell said that $16,000 worth of product was stolen from her shop last month – and they attempted to rob the place again just two weeks later. She said the group seems “aware that police don’t have quick response times” and were in the shop for at least 25 minutes while the alarm “was going off the entire time.”

Dispensary owners told WW that they believe the robbers map out their routes since multiple shops in the same parts of town – often on the same street – are being targeted on the same night.

Earlier this year, police in Portland and Salem said they were investigating a burglary ring and had made one arrest which led to $33,000 in cash, 30 pounds of cannabis, six pounds of hash oil, 16 firearms, and burglary tools, along with clothing and other evidence from the victimized businesses.

End

Study: Patients Don’t Consider Doctors Good Source of Medical Cannabis Info

8/19/2020

by

According to researchers at the University of Vermont, the majority of medical cannabis patients in the state do not believe their primary care doctor is a “good source of information regarding cannabis.”

In a study published in the Journal of Primary Care & Community Health surveying 1,009 Vermont primary care patients, the researchers found 45 percent of respondents used cannabinoids over the past year but just 18 percent of those patients said their primary care physician was a good resource for information on cannabis.

The median age of the respondents was 51-years-old.

The majority of patients surveyed who used cannabis said it was helpful for conditions such as anxiety, depression, arthritis, pain, sleep, and nausea. Medical cannabis has been legal in Vermont since 2004.

“Primary care providers need to be knowledgeable about cannabinoids to best support patient care. In addition, with a significant number of patients reporting cannabinoids helpful for medical conditions common in primary care, it is important that research continue to identify the potential benefits and harms of cannabis.” – “Use and Reported Helpfulness of Cannabinoids Among Primary Care Patients in Vermont,” Jan-Dec 2020, Journal of Primary Care & Community Health

The researchers said the knowledge gap among primary care physicians results in “providers having difficulty navigating conversations surrounding cannabinoid use.”

A 2017 survey of medical school curriculum deans conducted by researchers at the Washington University School of Medicine in St. Louis, Missouri found that 66.7 percent of respondents indicated their graduates were not prepared to recommend medical cannabis and another 25 percent said their graduates were not even prepared to answer medical cannabis questions.

Other surveys have consistently purported that medical professionals do not believe they know enough about the health and safety effects of cannabis.

End

Massachusetts Division of Alcoholism Administration Funded By Cannabis Taxes

8/19/2020

by

The majority of cannabis-derived state excise taxes in Massachusetts – $53.8 million of the $78.8 million spent through July – has been allocated to the state Division of Alcoholism Administration, while another $20.7 million was used to pay for the Cannabis Control Commission, according to state figures outlined by the Boston Business Journal.

Under the state’s recreational cannabis law, the Legislature can allocate cannabis excise taxes to public and behavioral health – part of the duties performed by the Alcoholism Administration – public safety, and municipal police training. In all, the state has taken in $65.63 million in excise taxes since fiscal year 2019.

The $38.16 million in cannabis-derived sales taxes is earmarked for the state’s General, Massachusetts Bay Transit Authority, and School Building Authority funds. In 2019, the state saw $8.11 million in cannabis sales taxes and $30.05 million in fiscal year 2020, which ended last month.

The local option tax – imposed by municipalities up to 3 percent – has totaled $18.28 million since 2019 but there is no state tracking of these funds; however, a review by the journal suggests the cities and towns are sent to their General Funds. The controversial “community impact fee” – which can be as much as 3 percent and is collected from operators – is not included in sales tax revenues.

Northampton – one of the first towns to allow recreational sales in the state – reported $2.6 million in community impact fees which was used for infrastructure upgrades, including roads, sidewalks, parking, and crosswalks.

Since the market’s launch, Massachusetts has collected $122 million in tax revenues from legal cannabis sales.

End

Supreme Court Urged to Hear Argument Against Cannabis Prohibition

8/18/2020

by

Attorneys Michael Hiller and Joseph Bondy are asking the U.S. Supreme Court to hear their case challenging the constitutionality of cannabis prohibition. The plaintiffs in the case include 14-year-old legalization activist Alexis Bortell, Iraq War veteran Jose Belen, and 9-year-old Jagger Cotte, who say cannabis treatment keeps them alive.

The lawsuit argues that cannabis’s Schedule I status under the Controlled Substances Act is “unconstitutionally irrational” and violates the patients’ “fundamental rights to equal protection under the law, substantive due process, and to preserve their health and lives” using cannabis as a medicine.

The lawsuit was originally filed in the Southern District of New York and was dismissed in 2018 by Judge Alvin Hellerstein, who ruled that the plaintiffs had not exhausted the administrative remedies – a petition process through the Drug Enforcement Agency – before filing their suit. A Second Circuit Court of Appeals reinstated the complaint but ultimately ruled with the District Court but held the petition in abeyance pending the plaintiffs scheduling of the petition with the DEA; while the DEA was directed to respond to an administrative petition.

“Notwithstanding the Second Circuit’s ruling, the DEA and D.C. Circuit Court have consistently ruled since 1977 that filing a de-scheduling petition of the sort directed by the Second Circuit and the District Court would be futile, since cannabis cannot be de-scheduled administratively or even be reclassified lower any than Schedule II under the CSA. In other words, the plaintiffs were directed to proceed with an administrative review process doomed to failure. Accordingly, they filed their petition with SCOTUS.” – Hiller and Bondy in a press release

Bondy, who is serving as pro-bono co-counsel on the case, said he expects organizations, activists, and members of Congress to file “friend of the court” amicus briefs in support of the petition.

Hiller, whose law firm Hiller PC is handling the case pro bono, said that while the nation’s highest court grants few such petitions, he is hopeful it will accept the jurisdiction of the appeal due to the “mass uncertainty” in cannabis laws, “conflicting decisions among the courts,” the “millions of Americans” who rely on medicinal cannabis, and “tens of billions in capital invested by businesses throughout the country to mass-produce a product, the legality of which is completely unclear.”

A decision on the petition is not expected until next year.

End

CBD Oil: A How-To Guide for At-Home Extractions

8/18/2020

by

British pharmaceutical company GW Pharmaceuticals recently received FDA approval of their oral solution Epidolex for treating seizures associated with Tuberous Sclerosis, adding another condition to the list of health issues that their CBD oil solution can successfully and safely treat. Individual users, however, claim that cannabis oil helps reduce pain and anxiety, as well as other issues that still await clinical confirmation.

Apart from its medicinal use, CBD oil can also be used to cook various dishes, sauces, dressings, and gummies. The wave of legalization that has swept North America recently also allowed entrepreneurs to start-up businesses and sell oil and other products made via CBD extraction to a wide array of consumers, not only those with medicinal needs.

If you’re looking for a way to make your own oil, however, this article is here to show you how to extract CBD from a cannabis plant at home.

Distinct types of CBD oil

Depending on the strain you use and the preparation method, there are three different types of CBD oil:

  • Full Spectrum
  • Broad Spectrum
  • CBD Isolate

Each of these three types of products provides a separate set of compounds and effects. It’s very important to know what you’re introducing into your system, especially when it comes to potentially psychoactive substances.

Full Spectrum CBD oil contains more than just CBD; there’s a wide array of other cannabinoids, including THC, terpenes, and essential oils. This type of CBD oil allows the use of both leaves and flowers to assure the presence of every compound; however, leaves hold a high concentration of chlorophyll, which gives the oil a dark color and a somewhat bad taste.

Broad Spectrum CBD oil gives you the full set of substances, as well, however, there is no THC, which means you won’t get high or show positive on a drug test if you consume the oil on a regular basis.

CBD Isolate is the purest form of CBD oil extracted from nothing but the plant flower. If you’re opting for this type of oil, you should use hemp flower for this purpose. Hemp has been legal in the U.S. since the passage of the 2018 Farm Bill.

Since the extraction of Full Spectrum CBD oil is the way to obtain the most of the plant’s benefits to our wellbeing, we’ll go through to examine this method, not only because buying complex equipment for marijuana processing might get you in trouble, but also because it’s the simplest process and easy to implement at home. For those of you who would like to know other methods of marijuana oil extraction, we’ll also mention some alternatives at the end.

Extracting CBD oil from a flower

Before you start the process, it’s of paramount importance to know that Ethanol or Ethyl Alcohol is a highly flammable substance so make sure you take every precaution to keep yourself and your environment safe from fire hazard. That being said, let’s get on with the preparation process.

What do you need?

Cannabis flowers – make sure you trim down every leaf and leave nothing but the flower for the extraction process. Break larger buds into smaller pieces to make it easier for processing or even better, grind the flower so that the herb could absorb the alcohol better.

Ethanol – Best use 95% Food-Grade Ethyl alcohol.
Filtering equipment – Best use paper filters or fold gauze into several layers.
Fireproof bowl – the size of the bowl depends on how much material you have prepared.
Large glass jar – This is where you’ll mix alcohol and weed.

Decarboxylation process

To activate cannabinoids, we must place the ground herb into an oven for about 45 minutes. Spread marijuana over a casserole dish or something similar and keep the oven heated at around 110 degrees Celsius. Depending on the granulation, it could take less than 45 minutes for the decarboxylation process, so pay attention not to burn your weed in the oven.

Mixing and filtering

Place your weed into the jar and pour alcohol over it until it covers the weed completely. Stir the mixture every 5 minutes several times and let the mix sit for an hour or two. You can’t let it sit for too long, so don’t worry if you leave it sitting longer than this.

Place the layered gauze or paper filter over the fireproof bowl and start pouring the solution. It’s not a bad idea to repeat the filtering process several times until you’re satisfied with the achieved purity of the filtered solution.

Removing the alcohol

Ethyl alcohol boils at 78 degrees Celsius which is the temperature you should set on your heating surface and slowly mix the solution within the fireproof bowl. Keep the bowl over the heat source until no alcohol vapor or bubbles is appearing on the surface of the heated liquid.

More oil extraction methods

There are numerous ways to extract oil, some even answer the question of how to extract THC from your product. As these require a bit more experience, we’ll only go through some of the most popular methods.

CO2 Extraction

This is one of the newest ways to produce CBD oil and it offers the purest oil extract, called CBD Isolate, free of any additional compounds. It requires a CO2 machine because it relies on carbon dioxide as a solvent. The herb is being placed into a Co2 machine and kept under pressure. This process also includes the Winterization and Decarboxylation process. The first is used to separate CBD from wax and lipids that might be left, while Decarboxylation activates the CBD.

Oil method

Similar to Ethanol extraction, the oil method requires the use of olive or coconut oil as a solvent. One major difference is that the herb is being mixed with water and dehydrated before it’s mixed with the oil and heated. This method is most commonly used by people who need to create CBD tinctures or topicals that can be applied directly to the affected area and deal with muscle pain.

We hope this article has helped you capture the basics of CBD oil extraction. We tried to cover the extraction process as comprehensively as possible so you wouldn’t have any setbacks while trying to make your extract at home. Also, we avoided the use of specialized chemistry equipment because, let’s face it, not too many people have a lab set up in the house. Enjoy your new knowledge and have fun making your CBD oil.

End